Selected data models

You must log in to select data models for download or further analysis.

7 Search results.
Relevance Rating New first Old first

Eligibility Elevated PSA NCT02425228

- 3/27/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02425228

Bioavailability and Pharmacokinetics of Testosterone with/without Dutasteride - 106218 - Screening Visit - Local Laboratory Result Data - PSA

- 3/4/19 - 1 form, 1 itemgroup, 3 items, 1 language
Itemgroup: Prostate-Specific Antigen
Study ID: 106218 Clinical Study ID: TDC106218 Study Title: Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride  Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: testosterone Trade Name: Andropatch,Androderm Study Indication: Hypogonadism, Male

Bioavailability and Pharmacokinetics of Testosterone with/without Dutasteride - 106218 - Part 2 - Screening Visit - Local Laboratory Result Data (PSA)

- 3/4/19 - 1 form, 2 itemgroups, 4 items, 1 language
Itemgroups: Administrative documentation, Laboratory Procedures, Prostate specific antigen measurement
Study ID: 106218 Clinical Study ID: TDC106218 Study Title: Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride  Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: testosterone Trade Name: Andropatch,Androderm Study Indication: Hypogonadism, Male

Basic Data PSMA-Study Prostate Cancer NCT0000001 - Stammdaten 2 PSMA-Studie Prostatakarzinom NCT0000001

- 1/9/18 - 1 form, 9 itemgroups, 48 items, 1 language
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Source: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Part: Stammdaten 2

PSA results GSK study Prostatic neoplasms NCT00883909

- 11/26/17 - 1 form, 2 itemgroups, 4 items, 1 language
Itemgroups: Administrative data, PSA results
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

PSA Before Therapy PSMA-Studie Prostatakarzinom NCT0000001 - PSA vor Therapie PSMA-Studie Prostatakarzinom NCT0000001

- 7/14/16 - 1 form, 2 itemgroups, 13 items, 2 languages
Itemgroups: Patient Data, Measurements
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: PSA vor Therapie

Stammdaten 1 PSMA Therapie NCT0000001

- 7/3/16 - 1 form, 1 itemgroup, 39 items, 2 languages
Itemgroup: Stammdaten
PSMA Therapie NCT0000001 Teil: Stammdaten 1

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial